The insulin receptor is the defining member of a family of protein(tyrosine) kinases. This family includes receptors for insulin- like growth factor, and hepatocyte growth factor, as well as Drosophila sevenless, Ros, and the UR2 transforming oncogene. The defining molecular feature is a conserved cluster of three tyrosines within the catalytic core of the kinase. Autophosphorylation of these tyrosines leads to activation of substrate phosphorylation. This activation is essential to the biological function of these kinases. However, the kinase domain of each family member is distinguished by unique autophosphorylation sites that are related to their respective unique cellular functions. Signal transduction through this family of receptors depends on the cellular environment and stimulation by the growth factor or hormone. The former is permissive of the biological effects, and the latter is necessary to raise the kinase from a basal to an activated state. At least four specific features of the kinase domain are intrinsic to this process of activation and thus to signal transduction: 1. """"""""core"""""""" autophosphorylation that activates the kinase, 2. """"""""subdomain"""""""" autophosphorylation characteristic of each kinase, which separately or together lead to 3. recognition of adapter proteins, and 4. phosphorylation of substrates. Thus, the apex of signal transduction for these receptors is activation of the kinase domain. The broad objective is to understand the molecular differences between basal and activated states of these tyrosine kinases that are activated by autophosphorylation. The specific objectives of this proposal are to examine (1) the molecular mechanisms that link autophosphorylation of the core tyrosines to kinase activation, and (2) the mechanisms that regulate reaction of the unique autophosphorylation sites. Each mechanism encompasses a set of conserved regulatory motifs that can be understood at the molecular level through rationally designed mutagenesis. Kinetics and physical- chemical measurements will then reveal both the catalytic events and conformational changes that are necessary and sufficient for activation. The early stages of this work focus on the isolated cytoplasmic kinase domain of the insulin receptor, which is more accessible for the proposed kinetic and physical studies. The long-term goals are to reconstruct activation via kinase domain interactions between transmembrane beta-subunits, and ultimately to establish the molecular mechanism of activation by insulin through binding to the alpha-subunit of the intact receptor.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK050074-01
Application #
2151068
Study Section
Biochemistry Study Section (BIO)
Project Start
1995-08-01
Project End
1998-07-31
Budget Start
1995-08-01
Budget End
1996-07-31
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Biochemistry
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10029
Till, J H; Ablooglu, A J; Frankel, M et al. (2001) Crystallographic and solution studies of an activation loop mutant of the insulin receptor tyrosine kinase: insights into kinase mechanism. J Biol Chem 276:10049-55
Ablooglu, A J; Kohanski, R A (2001) Activation of the insulin receptor's kinase domain changes the rate-determining step of substrate phosphorylation. Biochemistry 40:504-13
Ablooglu, A J; Till, J H; Kim, K et al. (2000) Probing the catalytic mechanism of the insulin receptor kinase with a tetrafluorotyrosine-containing peptide substrate. J Biol Chem 275:30394-8
Bishop, S M; Ross, J B; Kohanski, R A (1999) Autophosphorylation dependent destabilization of the insulin receptor kinase domain: tryptophan-1175 reports changes in the catalytic cleft. Biochemistry 38:3079-89
Frankel, M; Bishop, S M; Ablooglu, A J et al. (1999) Conformational changes in the activation loop of the insulin receptor's kinase domain. Protein Sci 8:2158-65
Wang, R; Chait, B T; Wolf, I et al. (1999) Lysozyme degradation by the bovine multicatalytic proteinase complex (proteasome): evidence for a nonprocessive mode of degradation. Biochemistry 38:14573-81
Cann, A D; Bishop, S M; Ablooglu, A J et al. (1998) Partial activation of the insulin receptor kinase domain by juxtamembrane autophosphorylation. Biochemistry 37:11289-300
Cardozo, C; Kohanski, R A (1998) Altered properties of the branched chain amino acid-preferring activity contribute to increased cleavages after branched chain residues by the ""immunoproteasome"". J Biol Chem 273:16764-70
Chen, J; Sadowski, H B; Kohanski, R A et al. (1997) Stat5 is a physiological substrate of the insulin receptor. Proc Natl Acad Sci U S A 94:2295-300
Cann, A D; Wolf, I; Kohanski, R A (1997) A tyrosine kinase assay using reverse-phase high-performance liquid chromatography. Anal Biochem 247:327-32

Showing the most recent 10 out of 11 publications